Viewing Study NCT03717103


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-29 @ 5:38 PM
Study NCT ID: NCT03717103
Status: COMPLETED
Last Update Posted: 2022-04-07
First Post: 2018-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module